Cellectis S.A. (CMVLF) has a profit margin of -506.95%, below the Healthcare sector average of 21.75%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2026
Trailing 12 months ending Sep 2026
As of the most recent data (September 2026), CMVLF shows a profit margin of -506.95%. That compares with -47.23% in the prior-year period — down 973.3% year over year. That is below the Healthcare sector average of 21.75%. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, CMVLF's profit margin is now -506.95% (was -47.23%) — a 973.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Cellectis S.A. is outperforming or lagging.
The Healthcare sector average profit margin is about 21.75%. Cellectis S.A. is at -506.95%, which is lower that average. That is roughly 2431.1% below the sector mean. Use the comparison chart on this page to see how CMVLF stacks up against individual peers as well.
That compares with -47.23% in the prior-year period — down 973.3% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Cellectis S.A. with peers to see if the move is company-specific or sector-wide.
Besides this profit margin page, Stockcircle has Cellectis S.A.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -506.95%) with ownership activity and broader fundamentals.